Thelium Therapeutics Inc. — Form D
Thelium Therapeutics Inc. of SAN CARLOS, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-05-05. The offering totals $18.1M, of which $3.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-05-05
- Form: D
- Accession: 0001926260-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $18.1M
- Amount sold: $3.1M
- Remaining: $15.0M
- Investors: 10
- Date of first sale: 2022-04-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-444578
Issuer
- Name: Thelium Therapeutics Inc.
- CIK: 0001926260
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 930 BRITTAN AVE, SAN CARLOS, CA, 94070-4002
- Phone: 415-988-2950
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Miro Brajenovic | Director | San Carlos, CA |
| Miro Brajenovic | Executive Officer | San Carlos, CA |
More